CCRAS calls for stronger evidence and safety monitoring to unlock Ayurveda market adoption
India’s Ayurvedic medicines and wellness category may face higher expectations on scientific validation, adverse-event reporting and pharmacovigilance. CCRAS says stronger safety systems are needed to build consumer trust, credibility and broader market adoption.
What happened
CCRAS called for stronger scientific validation, adverse-event reporting and pharmacovigilance for Ayurvedic medicines and therapies, aiming to improve safety, credibility and market adoption in India’s growing Ayurveda and wellness category.
Key facts
- Two-day symposium
- 1996
Why this matters
Acquirers should prioritize targets with validated formulations, documented safety systems and regulatory capabilities as these assets become more important to category adoption.
What to watch
- CCRAS, AYUSH or CDSCO issuance of formal pharmacovigilance, labeling, clinical-evidence or advertising guidelines.
- Mandatory adverse-event reporting requirements or a centralized Ayurveda safety-reporting database.
- Marketplace and quick-commerce policy changes requiring test certificates, claim substantiation or compliance documentation.
- Rising product recalls, safety controversies or consumer litigation involving Ayurvedic formulations.
- Major brands publishing clinical trials, safety dashboards or third-party certification programs.
- Modern retail chains creating science-backed Ayurveda assortments or excluding unverified products.
- Audit Ayurveda SKUs for substantiation, contraindication language, dosage instructions and adverse-event escalation processes.
- Create a tiered claims framework separating traditional-use claims from clinically validated efficacy claims.
- Prioritize suppliers with GMP compliance, batch traceability, standardized extracts and documented safety monitoring.
- Build retailer-facing evidence packs for high-volume products and restrict unsupported digital marketing claims.
- Monitor acquisition or partnership opportunities among testing labs, clinical-research providers and credible regional Ayurveda brands.